Tag: Cmv retinitis

Foscarnet is an antiviral medication, not a chemotherapy drug, primarily used to treat and prevent severe viral infections in immunocompromised individuals. Its use in patients undergoing cancer treatment is often a source of confusion, but it is administered to address opportunistic viral infections rather than to combat cancer itself. This article clarifies the distinction by exploring the different mechanisms and applications of these two drug classes.

Before the advent of highly active antiretroviral therapy (HAART), Cytomegalovirus (CMV) retinitis affected 25-40% of all AIDS patients. Foscarnet is a crucial antiviral medication used to treat these and other serious viral infections. So, **what class of drug is Foscarnet**? It is classified as a pyrophosphate analog DNA polymerase inhibitor.

Over 80% of adults worldwide are seropositive for cytomegalovirus (CMV), a common virus that poses little threat to healthy individuals. However, for those with weakened immune systems, CMV can lead to severe complications, making medication like **Cytoniche 450 mg** a critical treatment option. This powerful antiviral helps manage and prevent serious CMV infections in vulnerable patient populations.

Originally FDA-approved in 1996, cidofovir is an intravenous antiviral medication used to treat cytomegalovirus (CMV) retinitis in patients with AIDS. This article explores the question, 'What is cidofovir used for?', covering its mechanism, primary indication, and significant off-label uses.

Over 90% of oral medications contain inactive ingredients, known as excipients, which are essential for the drug's delivery and stability [1.6.4]. The term 'VG pills' is ambiguous; therefore, this article will clarify its multiple potential meanings in pharmacology, including its role as an excipient, a specific antiviral drug, and a class of unregulated supplements.